Jason A DelCarpini

Statistics

Publications

Citations

106

H-Index

Active since

2016

Affiliations

Celldex Therapeutics (United States)(Current)

Pfizer (United States)

Jason A DelCarpini is an author at Celldex Therapeutics (United States) specializing in pharmacy, biopharmaceutics, and biological reagent management.

Publications per year

2016–2019

Publications

2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 – Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)

Steven P. Piccoli, Devangi Mehta, Alessandra Vitaliti et al. · Bioanalysis · 2019 · 95 citations · Full text

Pharmacy, Biomedical Sciences, Biopharmaceutics +13

Mitigation of Pre-existing Antibodies to a Biotherapeutic in Non-clinical Species When Establishing Anti-drug Antibody Assay Cutpoint

Seema C Kumar, Jason A DelCarpini, Qiang Qu et al. · The AAPS Journal · 2016 · 11 citations

Pharmacy, Immunology, Pharmacology +16

1–2 of 2